Director/PDMR Shareholding
Updated : 15:45
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 15 April 2020, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:
Name of PDMR | Number of shares subject to option | |
Stuart Quin |
| 615,385 |
Dr Stephen Davies |
| 180,995 |
Kevin Terrins |
| 117,647 |
Sarah Burns |
| 117,647 |
Marc O'Brien |
| 162,896 |
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation, and set out more details of the transactions.
1. | Details of PDMR | |
(a) | Name | 1. Stuart Quin 2. Dr Stephen Davies 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien
|
2. | Reason for notification | |
(b) | Position / status | 1. Chief Executive Officer 2. Medical Director and Responsible Officer 3. Business Development Director 4. Chief Operating Officer 5. Chief Technical Officer
|
(c) | Initial notification / amendment | Initial notification in each case |
3. | Details of the Issuer | |
(a) | Name | Medica Group PLC |
(b) | LEI | 213800B8XE5FUSZF5Z16 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted | |
(a) | Description of the financial instrument | Ordinary shares of 0.2p each in the capital of the Company ("Shares") |
(b) | Nature of the transaction | Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017 |
(c) | Price(s) and volume | Option Price nil in each case 1. 615,385 2. 180,995 3. 117,647 4. 117,647 5. 162,896
|
(d) | Aggregated information | N/A |
(e) | Date of the transaction | 15 April 2020 |
(f) | Place of the transaction | Outside a trading venue |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.